Alzheimer’s disease (AD) involves the buildup of harmful proteins in the brain. Hereditary changes in the brain resident immune cells, called microglia can strongly affect this process. One of the…
Lee mas
Novo Nordisk today announced disappointing topline results for two clinical trials, EVOKE and EVOKE+, of their GLP-1 agonist semaglutide for Alzheimer’s disease. Semaglutide is approved for treatment of diabetes and…
Lee mas
The post Sharing Alzheimer’s Education to the Spanish-Speaking Community in Southern California appeared first on UCI MIND.
Lee mas
Drs. Kevin Beier and Elizabeth Head, both faculty members of UCI MIND, along with co-investigators Drs. Liz Chrastil and Jing Zhang have been awarded a 4 year NIH grant to…
Lee mas
UCI MIND is in the spotlight again with the announcement of large collaborative NIA grant to study LATE. Read the article in the UC Irvine News The post UCI MIND…
Lee mas